Attached files
| file | filename |
|---|---|
| 10-K - 10-K - SYNERGY PHARMACEUTICALS, INC. | a15-1897_110k.htm |
| EX-21 - EX-21 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex21.htm |
| EX-10.9 - EX-10.9 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex10d9.htm |
| EX-10.3 - EX-10.3 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex10d3.htm |
| EX-10.4 - EX-10.4 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex10d4.htm |
| EX-31.1 - EX-31.1 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex31d1.htm |
| EX-32.2 - EX-32.2 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex32d2.htm |
| EX-32.1 - EX-32.1 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex32d1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SYNERGY PHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-31.2 - EX-31.2 - SYNERGY PHARMACEUTICALS, INC. | a15-1897_1ex31d2.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
Synergy Pharmaceuticals Inc.
New York, New York
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File Nos. 333-163316, 333-177730 and 333-182271) and Form S-8 (File No. 333-193349) of Synergy Pharmaceuticals Inc. and Subsidiaries (the “Company”) of our reports dated March 16, 2015, relating to the consolidated financial statements and the effectiveness of the Company’s internal control over financial reporting which appear in this annual report on Form 10-K.
|
/s/ BDO USA, LLP |
|
|
New York, New York |
|
March 16, 2015